0

544738

SPML

img img img img
No Data Available

Speciality Medicines Ltd Share Price Update

As of the latest trading session, Speciality Medicines Ltd share price is currently at ₹197.15, which is up by ₹25.95 from its previous closing. Today, the stock has fluctuated between ₹195.00 and ₹205.40. Over the past year, Speciality Medicines Ltd has achieved a return of [-]%. In the last month alone, the return has been 29.50%.

Investment Returns

Over 1 Month [-]% Over 3 Months 0.00% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Speciality Medicines Ltd fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    150.40

  • P/E Ratio (TTM)

    16.64

  • Beta

    0.65

  • Book Value / share

    67.78

  • Return on equity

    37.85%

  • EPS (TTM)

    9.80

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Speciality Medicines Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 58.27
Operating Expense 49.85
Net Profit 8.61
Net Profit Margin (%) 14.77
Earnings Per Share (EPS) 14.10
EBITDA 9.36
Effective Tax Rate (%) 0.92
Particulars MAR 2024 (Values in Cr)
Revenue 27.52
Operating Expense 23.10
Net Profit 2.93
Net Profit Margin (%) 10.64
Earnings Per Share (EPS) 7.07
EBITDA 5.39
Effective Tax Rate (%) 35.52
Particulars MAR 2023 (Values in Cr)
Revenue 23.24
Operating Expense 20.31
Net Profit 1.69
Net Profit Margin (%) 7.27
Earnings Per Share (EPS) 4.72
EBITDA 3.59
Effective Tax Rate (%) 42.71
Particulars MAR 2022 (Values in Cr)
Revenue 40.44
Operating Expense 38.31
Net Profit 1.48
Net Profit Margin (%) 3.65
Earnings Per Share (EPS) 70.45
EBITDA 2.28
Effective Tax Rate (%) 30.84
Particulars MAR 2025 (Values in Cr)
Book Value / Share 47.26
ROE % 37.85
ROCE % 34.34
Total Debt to Total Equity 0.17
EBITDA Margin 16.13
Particulars MAR 2024 (Values in Cr)
Book Value / Share 29.44
ROE % 27.98
ROCE % 37.57
Total Debt to Total Equity 0.31
EBITDA Margin 19.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.36
ROE % 43.33
ROCE % 52.17
Total Debt to Total Equity 0.62
EBITDA Margin 15.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 92.02
ROE % 76.68
ROCE % 69.55
Total Debt to Total Equity 0.61
EBITDA Margin 5.64
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.84
Total Assets 39.98
Total Liabilities 39.98
Total Equity 30.41
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 21.53
Return on Capital (%) 24.27
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.24
Total Assets 22.68
Total Liabilities 22.68
Total Equity 15.06
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 12.93
Return on Capital (%) 16.37
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.26
Total Assets 13.26
Total Liabilities 13.26
Total Equity 5.86
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 12.73
Return on Capital (%) 17.76
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 5.77
Total Liabilities 5.77
Total Equity 1.93
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 25.61
Return on Capital (%) 47.57
Particulars MAR 2025 (Values in Cr)
Net Income 8.69
Cash from Operations -5.79
Cash from Investing -2.06
Cash from Financing 8.46
Net change in Cash 0.59
Free Cash Flow -5.18
Particulars MAR 2024 (Values in Cr)
Net Income 4.55
Cash from Operations -3.51
Cash from Investing -0.02
Cash from Financing 4.81
Net change in Cash -0.01
Free Cash Flow -3.48
Particulars MAR 2023 (Values in Cr)
Net Income 2.95
Cash from Operations -3.61
Cash from Investing 0.03
Cash from Financing 4.36
Net change in Cash 0.18
Free Cash Flow -3.53
Particulars MAR 2022 (Values in Cr)
Net Income 2.13
Cash from Operations 0.80
Cash from Investing -2.33
Cash from Financing 1.60
Net change in Cash 0.07
Free Cash Flow 2.89
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 28.66 12.41 1.48 219.63 23.12 41.45
BLISS GVS PHARMA LTD. 261.00 24.95 2.43 2761.09 105.05 265.00
CIPLA LTD 1211.30 20.58 2.97 97846.71 1165.55 1672.20
FERMENTA BIOTECH LIMITED 325.80 10.84 2.45 958.86 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2409.85 40.59 23.90 40824.31 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 28.66 27.56 3.99 219.63 23.12 41.45
AMRUTANJAN HEALTH CARE LTD. 525.20 26.26 4.43 1518.39 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8718.05 104.77 27.27 21795.13 7630.00 10653.05
BLISS GVS PHARMA LTD. 261.00 35.56 2.50 2761.09 105.05 265.00

Speciality Medicines Ltd shareholding pattern

Holding

56.33%
43.42%
0.23%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Speciality Medicines Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
171.20 4.99 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 149.90
  • 26 Days 138.70
  • 10 Days 138.70
  • 50 Days 138.70
  • 12 Days 138.70
  • 100 Days 138.70
  • 20 Days 138.70
  • 200 Days 138.70
163.05 PIVOT

First Support

163.05

First Resistance

163.05

Second Support

163.05

Second Resistance

163.05

Third Support

163.05

Third Resistance

163.05

RSI

0.00

ADX

84.30

MACD

0.00

Williams % R

0.00

Commodity Channel Index (CCI)

309.18

Date

2026-04-13

Week

72167.00

Same Day

15000.00

Month

229444.00

1 Year

0.66

3 Year

0.64

Over 1 Month

29.50%

down

Over 1 Year

0.00%

down

Over 3 Months

0.00%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Speciality Medicines Ltd Corporate Actions

Top Gainers

Speciality Medicines Ltd Share Price

Speciality Medicines Limited was originally incorporated as 'Speciality Medicines Private Limited' as a Private Limited Company, dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre. Later on, the status was converted to Public Limited and the name of the Company was changed to 'Speciality Medicines Limited' and a fresh Certificate of Incorporation dated June 25, 2024 was issued to the Company by Registrar of Companies.

The Company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market. The Company has presence over 35 countries.

The Company deal in Specialty pharmaceuticals finished formulations Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet, Suspension and Tablet. It provide a diverse portfolio of specialty pharmaceuticals, focusing on therapeutic areas such as oncology, immunology, neurology, and rare diseases. These products are designed to meet the complex needs of patients with chronic conditions, providing innovative solutions that improve health outcomes. The Company is collaborating with overseas distributors, many of whom work closely with the health ministries of various countries, as well as government and private hospitals.

Unlike traditional drugs, which are typically prescribed for common illnesses and follow simpler manufacturing processes, specialty medicines
are characterized by their advanced therapeutic properties and the complexity of their development, handling, and administration. Specialty medicines are characterized by their use in treating complex or rare diseases such as cancer, rheumatoid arthritis, multiple sclerosis, haemophilia, and genetic disorders, where standard therapies are often ineffective. They involve advanced technologies like biologics and gene therapies, making their research, development, and manufacturing highly sophisticated and costly, which results in higher prices compared to conventional drugs. These medicines require complex administration and handling, often needing refrigeration, injections, or infusions delivered in clinical settings or through specialty pharmacies. Additionally, they are supported by patient education, adherence programs, and ongoing monitoring to ensure effective treatment outcomes.

The Company issued and allotted 23,50,000 Equity Shares of Rs 10 each through IPO on 24 March 2026.

Parent organization Indian Private
NSE symbol [-]
Founded 2021
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Speciality Medicines Ltd?

Answer Field

Speciality Medicines Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 171.20 as on Apr 16 2026 10:15 AM.

What is the Market Cap of Speciality Medicines Ltd Share?

Answer Field

The market cap of Speciality Medicines Ltd for NSE ₹ 0.00 & for BSE ₹ 150.40 as on Apr 16 2026 10:15 AM.

What is the 52 Week High and Low of Speciality Medicines Ltd?

Answer Field

The 52 Week High and Low of Speciality Medicines Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 171.20 and ₹ 121.10.

What is 1 year return for Speciality Medicines Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Speciality Medicines Ltd Share?

Answer Field

As on Apr 16 2026 10:15 AM the price-to-earnings (PE) ratio for Speciality Medicines Ltd share is 16.64.

What is the PB ratio of Speciality Medicines Ltd Share?

Answer Field

As on Apr 16 2026 10:15 AM, the price-to-book (PB) ratio for Speciality Medicines Ltd share is 67.78.

How to Buy Speciality Medicines Ltd Share?

Answer Field

You can trade in Speciality Medicines Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Speciality Medicines Ltd Share on Bajaj Broking App?

Answer Field

To buy Speciality Medicines Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Speciality Medicines Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59